Lancet
Journal Abbreviation: LANCET
ISSN: 0140-6736
eISSN: 1474-547X
Publisher: Elsevier: Lancet
Publications (40)
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024)
Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al.
Journal article
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial (2024)
Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schönau V, Hueber A, et al.
Journal article
Adult epilepsy (2023)
Asadi-Pooya AA, Brigo F, Lattanzi S, Blümcke I
Journal article, Review article
CD19-targeted CAR T cells in refractory antisynthetase syndrome (2023)
Müller F, Böltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, et al.
Journal article
CAR T-cell therapy in autoimmune diseases (2023)
Schett G, Mackensen A, Mougiakakos D
Journal article, Review article
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. (2023)
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, et al.
Journal article
The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis (2023)
Atreya R, Neurath M
Journal article
Towards preventive treatment of rheumatoid arthritis (2022)
Rech J, Schett G
Journal article
Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19 (2022)
Archard D, Buyx A, Delfraissy JF
Journal article
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022)
Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al.
Journal article